Aspirin cuts prostate cancer risk by 30pc
August 12th, 2010 Posted in prostate cancer risksA new research at the Fred Hutchinson Cancer Research Centre in Seattle has shown that taking a low dose of aspirin every day can cut the risk of prostate cancer by almost 30 per cent.
According to scientists the painkiller works by blocking the effect of enzymes, which cause inflammation thought to be a key factor in the development of prostate cancer, so a 75mg tablet taken on a daily basis has a powerful protective effect against the disease.
The study is the latest in long line of investigations into whether aspirin can help prevent prostate tumours from forming.